Welcome to the 6th Cell Therapy Analytical Development Summit

"This summit highlights the need for continued conversations on analytical assay design for cell therapies. In 2024, I look forward to discussing major changes ushered into CGT development via the novel platform technology designation and potency assurance.”
Manager, Science & Industry Affairs, Alliance for Regenerative Medicine (2024 Speaker)

"With constantly evolving therapies and their regulations, it is important to have a space like this for the stakeholders to come together and share their knowledge and experiences.”
Senior Scientist, Process Development Drug Substance, Satellite Bio (2024 Speaker)

"I have been a regular attendee at this conference and it's always been a spot to meet new cell therapy SMEs and reconnect with some others.”
Head of Analytical Development, Takeda (2024 Speaker)

"The 6th Cell Therapy Analytical Development Summit is a pivotal event for advancing the field of cell therapy. It provides an unparalleled platform for sharing cutting-edge research, fostering collaborations, and addressing the latest challenges in analytical development. I am eagerly looking forward to the 2024 meeting in Boston to engage with industry leaders and contribute to the discussions that will shape the future of cell therapy.”
Director, Quality Assurance & Regulatory Affairs, University of Minnesota (2024 Speaker)

"I enjoyed the well-organized conference and streamlined tracks of different focus. I learned what the key questions are that all are interested in and need to be addressed, which will guide us to better develop cell therapy drugs.”
Principal Scientist, Merck & Co. (Past Attendee)

"Cell therapy processes and assays are very complex. We are looking forward to hearing about new technologies and innovations in cell therapy development. We also would like to learn the regulatory perspective towards release assays.”
Vice President, Cell Therapy, Aisaer/IxCell Biotechnology (2024 Speaker)